Semaglutide (Rybelsus) and metformin are two oral diabetes medications prescribed for treating type 2 diabetes. Even though they treat the same condition, they work differently. In this article, we’ll discuss what the medications are, how they compare, side effects, and how each one works to address symptoms of diabetes.
What Is Rybelsus?
Semaglutide, available as the brand name Rybelsus, is a newer type of medication for the treatment of type 2 diabetes. It is not available as a generic. Rybelsus is used on its own or with other medications like metformin to manage type 2 diabetes.
Rybelsus is a glucagon-like peptide-1 (GLP-1) agonist. This type of drug is otherwise only available as an injection. Rybelsus is the only oral medication in this class of drugs. Rybelsus was first approved by the U.S. Food and Drug Administration (FDA) in 2019. It is available as an oral tablet in three-, seven-, and 14-milligram (mg) strengths.
Talk to a doctor from home
Manage diabetes medications without leaving your house.
How does Rybelsus work?
Rybelsus is used to treat type 2 diabetes in combination with a healthy lifestyle, including diet and exercise. It helps lower blood sugar levels by acting like a hormone that the body makes in the gut called GLP-1. As a result, Rybelsus can stimulate the pancreas to release insulin after meals. Insulin takes glucose out of the blood and into the cells, lowering blood sugar levels and allowing glucose to be used as energy.
Rybelsus also stops the liver from releasing more sugar, which can help stabilize blood sugar levels. It can also slow down digestion, which can prevent higher spikes of blood glucose after meals.
What Is Metformin?
Metformin is a first-line medication for the treatment of type 2 diabetes. First approved in 1995, metformin is generally well-tolerated. It may be prescribed as an oral solution (Riomet), tablet, or extended-release tablet (Glumetza, others).
Metformin is FDA-approved for the treatment of type 2 diabetes in people ages 10 and older. Extended-release tablets are only approved for use in adults.
How does metformin work?
Metformin helps keep blood glucose levels stable in patients who have type 2 diabetes or other conditions that may impact glucose control. It reduces how much sugar is taken into the bloodstream and slows the liver from releasing more sugar. It also stimulates the body’s natural release of insulin.
Rybelsus vs Metformin: How Do They Compare?
While Rybelsus and metformin both treat type 2 diabetes and work to control blood sugar levels in the body, they have some differences.
Rybelsus | Metformin | |
Effective? | Yes, not first-line treatment | Yes, first-line treatment |
Common side effects | Diarrhea, nausea, vomiting, abdominal discomfort, reduced appetite, constipation | Diarrhea, nausea, upset stomach, vomiting, abdominal discomfort, gas, weakness |
Serious side effects | Rare but possible: thyroid tumors | Rare but possible: lactic acidosis |
Generic? | No | Yes |
Insurance coverage | Typically, varying copays | Yes, low or no copays |
Costs | Cash price with no assistance can range from $700-$1,200. | Cash price with no assistance averages $10. |
Efficacy
Both Rybelsus and metformin work to treat type 2 diabetes, and both can effectively lower hemoglobin A1C. Hemoglobin A1C is a blood test that measures a three-month average of a person’s glucose levels. It is often used in addition to other glucose and insulin tests to determine whether diabetes is well managed.
Side effects
Both medications can cause some common side effects.
Possible side effects of Rybelsus include:
- Diarrhea
- Nausea
- Vomiting
- Abdominal discomfort
- Reduced appetite
- Constipation
The most common side effects of metformin include:
- Diarrhea
- Nausea and upset stomach
- Vomiting
- Abdominal discomfort
- Gas
- Weakness
Though rare, serious side effects are possible for both medications. Possible serious side effects can include:
- Rybelsus: FDA black box warning for thyroid C-cell tumors. People who have a family or personal history of medullary thyroid cancer should not take Rybelsus. Other serious risks: inflammation of the pancreas (pancreatitis), kidney damage, and eye problems relating to diabetes.
- Metformin: FDA black box warning for lactic acidosis. Adults over age 65 and people who have liver disease are at higher risk from this complication, where lactic acid builds up to dangerous levels in the blood.
Warnings and risks
Both Rybelsus and metformin have a small chance of causing anaphylactic allergic reactions. Anyone who takes either medication and experiences the following symptoms should seek emergency medical care of call 911:
- Breathing problems
- Hives
- Rashes
- Chest pain
- Sudden vomiting
Both Rybelsus and metformin can interact with other medications. If taken incorrectly, both could lead to hypoglycemia (low blood sugar), which if not monitored properly can be serious. Neither medication should be combined with other medications for treating type 2 diabetes without a healthcare provider’s instructions.
Always tell your healthcare provider and pharmacist about any medications, OTC drugs, herbal supplements, or vitamins that you take. All can potentially lead to preventable drug interactions.
Cost
The cost of Rybelsus and metformin can vary widely.
- Rybelsus: Only available as a brand-name drug, a typical dosage and monthly supply of tablets can range from $700-$1,200 depending on location, pharmacy, and insurance coverage. Manufacturer patient assistance programs may lower the cost dramatically or provide Rybelsus at no cost to people who meet eligibility requirements.
- Metformin: Available as a generic, a typical dosage and monthly supply of tablets can range from $2-$20 depending on the location, pharmacy, insurance coverage, and the use of prescription savings programs.
Talk to a doctor from home
Manage diabetes medications without leaving your house.
Which Works Better for Type 2 Diabetes?
Both Rybelsus and metformin are effective for balancing blood sugar in people who have type 2 diabetes. The medication that works best depends on many factors, such as:
- Individual health and family history
- Tolerance of side effects
- Lifestyle changes like diet and exercise
- Other health conditions
- Accessibility and cost of medication
A medical provider will recommend the pharmaceutical medication that they believe will work best for a patient’s unique set of healthcare needs. If a medication is not covered by insurance or is not accessible because of cost, healthcare providers will work to find an effective and affordable treatment plan.
Bottom Line
Metformin has been used for almost three decades to treat type 2 diabetes. Rybelsus has only been used for a few years, but both provide similar results for balancing hemoglobin A1C levels.
Metformin is a first-line choice for healthcare providers, although Rybelsus is sometimes used with metformin or may be prescribed for people who are unable to take metformin.
How K Health Can Help
Did you know you can have a primary care doctor online?
Check your symptoms, explore conditions and treatments, and if needed, text with a healthcare provider in minutes through K Health. K Health’s AI-powered app is based on 20 years of clinical data.
Frequently Asked Questions
K Health has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references.
-
Rybelsus (semaglutide) tablets. (2021).
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213051s006lbl.pdf -
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. (2019).
https://pubmed.ncbi.nlm.nih.gov/31530667/ -
Rybelsus (semaglutide tablets). (2022).
https://www.novo-pi.com/rybelsus.pdf -
Metformin: Historical overview. (2017).
https://pubmed.ncbi.nlm.nih.gov/28776081/ -
Metformin hydrochloride. (2021).
https://www.accessdata.fda.gov/spl/data/b849b1fc-2e6f-91dc-e053-2a95a90a9286/b849b1fc-2e6f-91dc-e053-2a95a90a9286.xml -
Glucagon-like Peptide-1 receptor agonists. (2022).
https://www.ncbi.nlm.nih.gov/books/NBK551568/ -
Metformin. (2022).
https://www.ncbi.nlm.nih.gov/books/NBK518983/ -
Lactic acidosis. (2022).
https://www.ncbi.nlm.nih.gov/books/NBK470202/